Newcastle Disease Vaccine Market growth is projected to reach USD 343.9 Million in 2023, at a 4.13% CAGR by driving industry size, share, segments research, top company analysis, trends and forecast report 2024 to 2032.

Newcastle Disease Vaccine Market Size, Growth, Trends, Report 2032

Newcastle Disease Vaccine Market

Chapter 1: Introduction &emsp;1.1 Scope and Coverage Chapter 2:Executive Summary Chapter 3: Market Landscape &emsp;3.1 Industry Dynamics and Opportunity Analysis &emsp;&emsp;3.1.1 Growth Drivers &emsp;&emsp;3.1.2 Limiting Factors &emsp;&emsp;3.1.3 Growth Opportunities &emsp;&emsp;3.1.4 Challenges and Risks &emsp;3.2 Market Trend Analysis &emsp;3.3 Strategic Pestle Overview &emsp;3.4 Porter's Five Forces Analysis &emsp;3.5 Industry Value Chain Mapping &emsp;3.6 Regulatory Framework &emsp;3.7 Princing Trend Analysis &emsp;3.8 Patent Analysis &emsp;3.9 Technology Evolution &emsp;3.10 Investment Pockets &emsp;3.11 Import-Export Analysis Chapter 4: Newcastle Disease Vaccine Market by By Vaccine Type &emsp;4.1 Newcastle Disease Vaccine Market Snapshot and Growth Engine &emsp;4.2 Newcastle Disease Vaccine Market Overview &emsp;4.3 Live Attenuated &emsp;&emsp;4.3.1 Introduction and Market Overview &emsp;&emsp;4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F) &emsp;&emsp;4.3.3 Live Attenuated: Geographic Segmentation Analysis &emsp;4.4 Inactivated &emsp;&emsp;4.4.1 Introduction and Market Overview &emsp;&emsp;4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F) &emsp;&emsp;4.4.3 Inactivated: Geographic Segmentation Analysis &emsp;4.5 Thermostable &emsp;&emsp;4.5.1 Introduction and Market Overview &emsp;&emsp;4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F) &emsp;&emsp;4.5.3 Thermostable: Geographic Segmentation Analysis Chapter 5: Newcastle Disease Vaccine Market by By Species &emsp;5.1 Newcastle Disease Vaccine Market Snapshot and Growth Engine &emsp;5.2 Newcastle Disease Vaccine Market Overview &emsp;5.3 Chicken &emsp;&emsp;5.3.1 Introduction and Market Overview &emsp;&emsp;5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F) &emsp;&emsp;5.3.3 Chicken: Geographic Segmentation Analysis &emsp;5.4 Duck &emsp;&emsp;5.4.1 Introduction and Market Overview &emsp;&emsp;5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F) &emsp;&emsp;5.4.3 Duck: Geographic Segmentation Analysis &emsp;5.5 Goose &emsp;&emsp;5.5.1 Introduction and Market Overview &emsp;&emsp;5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F) &emsp;&emsp;5.5.3 Goose: Geographic Segmentation Analysis &emsp;5.6 And Others &emsp;&emsp;5.6.1 Introduction and Market Overview &emsp;&emsp;5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F) &emsp;&emsp;5.6.3 And Others : Geographic Segmentation Analysis Chapter 6: Company Profiles and Competitive Analysis &emsp;6.1 Competitive Landscape &emsp;&emsp;6.1.1 Competitive Benchmarking &emsp;&emsp;6.1.2 Newcastle Disease Vaccine Market Share by Manufacturer (2023) &emsp;&emsp;6.1.3 Concentration Ratio(CR5) &emsp;&emsp;6.1.4 Heat Map Analysis &emsp;&emsp;6.1.5 Mergers and Acquisitions &emsp;&emsp; &emsp;6.2 MERIAL (IRELAND) &emsp;&emsp;6.2.1 Company Overview &emsp;&emsp;6.2.2 Key Executives &emsp;&emsp;6.2.3 Company Snapshot &emsp;&emsp;6.2.4 Operating Business Segments &emsp;&emsp;6.2.5 Product Portfolio &emsp;&emsp;6.2.6 Business Performance &emsp;&emsp;6.2.7 Key Strategic Moves and Recent Developments &emsp;6.3 QYH BIOTECH (CHINA) &emsp;6.4 CEVA (FRANCE) &emsp;6.5 YEBIO (CHINA) &emsp;6.6 RINGPU (TIANJIN) BIO-PHARMACY CO. &emsp;6.7 LTD (CHINA) &emsp;6.8 BAYER AG (GERMANY) &emsp;6.9 HIPRA (SPAIN) &emsp;6.10 ANICON LABOR GMBH (GERMANY) &emsp;6.11 CHENGDU TECH-BANK BIOLOGICAL PRODUCTS CO. &emsp;6.12 LTD. (CHINA) &emsp;6.13 RINGPU BIO-TECHNOLOGY CO. &emsp;6.14 LTD. (CHINA) &emsp;6.15 MSD ANIMAL HEALTH (UNITED STATES) &emsp;6.16 NISSEIKEN CO. (JAPAN) &emsp;6.17 HARBIN VETERINARY RESEARCH INSTITUTE (CHINA) &emsp;6.18 MERCK ANIMAL HEALTH (UNITED STATES) &emsp;6.19 CHENGDU TECBOND (CHINA) &emsp;6.20 DHN (BRAZIL) &emsp;6.21 ZOETIS (UNITED STATES) &emsp;6.22 ELANCO (LOHMANN) (UNITED STATES) &emsp;6.23 CAVAC (FRANCE) &emsp;6.24 VAKSINDO (INDONESIA) &emsp;6.25 FATRO (ITALY) &emsp;6.26 OTHERS. Chapter 7: Global Newcastle Disease Vaccine Market By Region &emsp;7.1 Overview &emsp;7.2. North America Newcastle Disease Vaccine Market &emsp;&emsp;7.2.1 Historic and Forecasted Market Size by Segments &emsp;&emsp;7.2.2 Historic and Forecasted Market Size By By Vaccine Type &emsp;&emsp;7.2.2.1 Live Attenuated &emsp;&emsp;7.2.2.2 Inactivated &emsp;&emsp;7.2.2.3 Thermostable &emsp;&emsp;7.2.3 Historic and Forecasted Market Size By By Species &emsp;&emsp;7.2.3.1 Chicken &emsp;&emsp;7.2.3.2 Duck &emsp;&emsp;7.2.3.3 Goose &emsp;&emsp;7.2.3.4 And Others &emsp;&emsp;7.2.4 Historic and Forecast Market Size by Country &emsp;&emsp;7.2.4.1 US &emsp;&emsp;7.2.4.2 Canada &emsp;&emsp;7.2.4.3 Mexico &emsp;7.3. Eastern Europe Newcastle Disease Vaccine Market &emsp;&emsp;7.3.1 Historic and Forecasted Market Size by Segments &emsp;&emsp;7.3.2 Historic and Forecasted Market Size By By Vaccine Type &emsp;&emsp;7.3.2.1 Live Attenuated &emsp;&emsp;7.3.2.2 Inactivated &emsp;&emsp;7.3.2.3 Thermostable &emsp;&emsp;7.3.3 Historic and Forecasted Market Size By By Species &emsp;&emsp;7.3.3.1 Chicken &emsp;&emsp;7.3.3.2 Duck &emsp;&emsp;7.3.3.3 Goose &emsp;&emsp;7.3.3.4 And Others &emsp;&emsp;7.3.4 Historic and Forecast Market Size by Country &emsp;&emsp;7.3.4.1 Bulgaria &emsp;&emsp;7.3.4.2 The Czech Republic &emsp;&emsp;7.3.4.3 Hungary &emsp;&emsp;7.3.4.4 Poland &emsp;&emsp;7.3.4.5 Romania &emsp;&emsp;7.3.4.6 Rest of Eastern Europe &emsp;7.4. Western Europe Newcastle Disease Vaccine Market &emsp;&emsp;7.4.1 Historic and Forecasted Market Size by Segments &emsp;&emsp;7.4.2 Historic and Forecasted Market Size By By Vaccine Type &emsp;&emsp;7.4.2.1 Live Attenuated &emsp;&emsp;7.4.2.2 Inactivated &emsp;&emsp;7.4.2.3 Thermostable &emsp;&emsp;7.4.3 Historic and Forecasted Market Size By By Species &emsp;&emsp;7.4.3.1 Chicken &emsp;&emsp;7.4.3.2 Duck &emsp;&emsp;7.4.3.3 Goose &emsp;&emsp;7.4.3.4 And Others &emsp;&emsp;7.4.4 Historic and Forecast Market Size by Country &emsp;&emsp;7.4.4.1 Germany &emsp;&emsp;7.4.4.2 UK &emsp;&emsp;7.4.4.3 France &emsp;&emsp;7.4.4.4 Netherlands &emsp;&emsp;7.4.4.5 Italy &emsp;&emsp;7.4.4.6 Russia &emsp;&emsp;7.4.4.7 Spain &emsp;&emsp;7.4.4.8 Rest of Western Europe &emsp;7.5. Asia Pacific Newcastle Disease Vaccine Market &emsp;&emsp;7.5.1 Historic and Forecasted Market Size by Segments &emsp;&emsp;7.5.2 Historic and Forecasted Market Size By By Vaccine Type &emsp;&emsp;7.5.2.1 Live Attenuated &emsp;&emsp;7.5.2.2 Inactivated &emsp;&emsp;7.5.2.3 Thermostable &emsp;&emsp;7.5.3 Historic and Forecasted Market Size By By Species &emsp;&emsp;7.5.3.1 Chicken &emsp;&emsp;7.5.3.2 Duck &emsp;&emsp;7.5.3.3 Goose &emsp;&emsp;7.5.3.4 And Others &emsp;&emsp;7.5.4 Historic and Forecast Market Size by Country &emsp;&emsp;7.5.4.1 China &emsp;&emsp;7.5.4.2 India &emsp;&emsp;7.5.4.3 Japan &emsp;&emsp;7.5.4.4 South Korea &emsp;&emsp;7.5.4.5 Malaysia &emsp;&emsp;7.5.4.6 Thailand &emsp;&emsp;7.5.4.7 Vietnam &emsp;&emsp;7.5.4.8 The Philippines &emsp;&emsp;7.5.4.9 Australia &emsp;&emsp;7.5.4.10 New Zealand &emsp;&emsp;7.5.4.11 Rest of APAC &emsp;7.6. Middle East &amp; Africa Newcastle Disease Vaccine Market &emsp;&emsp;7.6.1 Historic and Forecasted Market Size by Segments &emsp;&emsp;7.6.2 Historic and Forecasted Market Size By By Vaccine Type &emsp;&emsp;7.6.2.1 Live Attenuated &emsp;&emsp;7.6.2.2 Inactivated &emsp;&emsp;7.6.2.3 Thermostable &emsp;&emsp;7.6.3 Historic and Forecasted Market Size By By Species &emsp;&emsp;7.6.3.1 Chicken &emsp;&emsp;7.6.3.2 Duck &emsp;&emsp;7.6.3.3 Goose &emsp;&emsp;7.6.3.4 And Others &emsp;&emsp;7.6.4 Historic and Forecast Market Size by Country &emsp;&emsp;7.6.4.1 Turkey &emsp;&emsp;7.6.4.2 Bahrain &emsp;&emsp;7.6.4.3 Kuwait &emsp;&emsp;7.6.4.4 Saudi Arabia &emsp;&emsp;7.6.4.5 Qatar &emsp;&emsp;7.6.4.6 UAE &emsp;&emsp;7.6.4.7 Israel &emsp;&emsp;7.6.4.8 South Africa &emsp;7.7. South America Newcastle Disease Vaccine Market &emsp;&emsp;7.7.1 Historic and Forecasted Market Size by Segments &emsp;&emsp;7.7.2 Historic and Forecasted Market Size By By Vaccine Type &emsp;&emsp;7.7.2.1 Live Attenuated &emsp;&emsp;7.7.2.2 Inactivated &emsp;&emsp;7.7.2.3 Thermostable &emsp;&emsp;7.7.3 Historic and Forecasted Market Size By By Species &emsp;&emsp;7.7.3.1 Chicken &emsp;&emsp;7.7.3.2 Duck &emsp;&emsp;7.7.3.3 Goose &emsp;&emsp;7.7.3.4 And Others &emsp;&emsp;7.7.4 Historic and Forecast Market Size by Country &emsp;&emsp;7.7.4.1 Brazil &emsp;&emsp;7.7.4.2 Argentina &emsp;&emsp;7.7.4.3 Rest of SA Chapter 8 Analyst Viewpoint and Conclusion 8.1 Recommendations and Concluding Analysis 8.2 Potential Market Strategies Chapter 9 Research Methodology 9.1 Research Process 9.2 Primary Research 9.3 Secondary Research

Newcastle Disease Vaccine Market Global Industry Analysis and Forecast (2024-2032) By Vaccine Type (Live Attenuated, Inactivated, Thermostable), By Species (Chicken, Duck, Goose, And Others) and Region

Buyer Information

Order Summary

Report	Newcastle Disease Vaccine Market
Selected License	Multi ID: IMR1740